Friday, January 22. 2016
"Breakthrough treatment for MS patient" - Is it really?
18 January 2016
According to this news story "doctors in Sheffield say patients with multiple sclerosis (MS) are showing "remarkable" improvements after receiving a treatment usually associated with cancer.
Tuesday, January 19. 2016
The term dorsiflexor weakness is not commonly known, but the symptoms it describes are familiar to many. This weakness develops in many patients who are later classed into 'multiple sclerosis'. When walking, the foot scuffs the ground. This is commonly known as drop foot.
For people with dorsiflexor weakness, every step requires high concentration because they tend to scuff their toes along the ground. Even a stone or a small uneven spot can become a big obstacle. Some people may swing the leg forward using their hip muscles. This requires more effort and leads to bad posture, which also results in back pain.
Functional electrical stimulation (FES) with MyGait® lifts the foot at just the right time in the walking, or gait cycle. Walking becomes faster and more efficient. With MyGait®.
MyGait® is a surface stimulator, acting on the nerves via electrodes placed on the skin to transform the way the patient walks.
A small switch the patient wears under the heel sends a wireless signal to the stimulator worn on a cuff just below the knee. The stimulator can then activate the muscles responsible for lifting the foot. This can result in an improved and more natural gait, reducing the risk of falls.
As the patient does not need to concentrate on the walking and constantly keep an eye on the ground, the mind is free for other thoughts, conversations and experiences. In addition, the muscles of the lower legs are exercised with FES, and strong muscles make walking even easier.
One of my patients who had many falls has started using MyGait® with remarkable results. To find out more Please click here
You can get a cheaper version here:
You can get these through the NHS physiotherapists too.
Friday, October 9. 2015
"Unconventional ideas in science are seldom positively greeted by those benefiting from conformity"
Marcell Truzzi Sociologist
Dr Mercola sheds light on the surreptitious methods used by various corporations:
Sunday, August 30. 2015
I am a 55yr old female, who apart from childhood/ early adult asthma and sports related wear and tear of the knee, elbow, shoulder and neck, (mild cervical spondylosis), had enjoyed 54 yrs of robust good health.
In December 2014 1 became ill, the symptoms were as follows:-
1) Severe, life altering dizziness;
2) Severe parasthesias (tingling) in arms and legs;
5) Unexplained, unwanted weight loss from 9 st to under 8 st, for my height, underweight.
My excellent GP whom I had rarely visited, ran many tests over several weeks
It was found that I had a positive ANA blood count that gradually rose from 1:80 to 1:320
(zero would be normal), indicative of an Auto Immune Disease.
This combined with my other symptoms meant that I was suspected of having either Multiple Sclerosis or Systemic Lupus Erythmatosus (SLE).
Extensive tests/ scans and investigations ensued with consultants in the following fields:-
Whilst waiting for the results of these tests, all of which eventually proved inconclusive, I found Dr Amir's website and arranged an appointment in Feb 2015.
Dr Amir is an exceptional man; kind, articulate, highly intelligent and an excellent Cranio Dental Surgeon, who has successfully treated many conditions when mainstream medicine has failed.
I have always known that my frame and jaw are not symmetrical, but, somewhat to my surprise, Dr Amir explained this could be causing all of my symptoms.
The following day he fitted two discreet braces to redress this imbalance, which I continue to wear. He also recommended specific exercises, some dietary changes and supplementation.
Now, 4 months later, my symptoms are hugely reduced and my health is returning to normal.
The life compromising dizziness is now intermittent and not severe. Sleep is no longer interrupted by the tingling which is barely perceptible.
My GP was delighted and surprised by all of this and in particular, that the ANA blood test has now reversed and returned to normal meaning it is back to Zero. He wanted to know if I'd been doing anything different to bring about this extraordinary change other than the physiotherapy that had been recommended to me to alleviate the cervical spondylosis.
As yet, I haven't told him of my regular consultations and treatment with Dr Amir, but will do so when all symptoms are completely resolved and my treatment is finished.
I am truly indebted to Dr Amir for his unswerving confidence and ability to bring about this dramatic turnaround in my health.
I will never be able to thank him enough.
Patient name withheld at her request.
Comment: I have had considerable flack from the MS Society and their shills in the past when any of my recovering patients have tried to post their outcomes on the MS Society blogs. They continue with their efforts to discredit me by not removing derogatory and slanderous blogs and have made very considerable and futile efforts to stop me helping patients. This testimonial flies in their face and so does the recovery of many other patients suffering from not only "Multiple Sclerosis" but very many other 'invented' illnesses.
Dr Mercola had a fantastic and a very apt piece in his article today:
"The food, chemical, and biotechnology industries have all built up intricate and powerful systems designed to manipulate public and scientific opinion using false front organizations and industry shills posing as independent experts.
The mission is to mislead people — including lazy reporters — about issues that threaten the corporate bottom line.
So-called astroturfing techniques are frequently used to discredit the opposition and create the false appearance of scientific consensus on a particular issue.
Astroturfing refers to the effort on the part of special interests to surreptitiously sway public opinion by making it appear as though there's a grassroots effort for or against a particular agenda, when in reality such a groundswell of public opinion might not exist.
One hallmark of astroturfing is attacking those who question the status quo, and using derogatory terms such as "crank," "crack," "nutty," "pseudo-science," and "conspiracy theorist" to describe them and their argument.
These shills also inject themselves into social media discussions, pretending to be "regular people," when in fact they have a very clearly defined agenda to steer the conversation."
This is an interesting developing story with a must watch video:
MS survivor pushing for major change at national charity in Canada
“This is a society that was created for people with MS; to defend us; to represent us; and to find us a cure. And given that only 16 per cent of their revenues are spent on researching a cure for MS, I question who the society is truly for."
Some comments by readers and 'MS' sufferers posted on the above website:
"Yes other charities work the same way but, how many are willing to point out the facts and go public? Thank you Matt for speaking out for 2.5 million of us who have this awful label of MS. Living off of us is disgusting. The MS Society of Canada have had over 67 years and they have no idea still what causes what they call MS Yet, they flog poisonous drugs just to keep us as customers. They do not want to end MS they want to live off of us. Period.".
"We need more people speaking out against these "charities", charities for health purposes that are funded or supported by big pharma need to be called out for what they really are, and that is a bunch of CEO's getting rich on the backs of sick people. Big pharma is taking over and literally killing people. When MS drugs cost thousand of dollars a month and some HIV drugs are simply unattainable for the people that need them, not to mention Cancer. It makes you wonder if people are manufacturing the diseases just to get people on the meds..."
Source:Calgary Herald Canada
More proof that 'MS' does not exist:
"Total Inspiration: Kevin Smith Kicks the Ass of Multiple Sclerosis"
The two links above show that in some cases taking up 'heavy' exercise on a daily basis and improving the quality of the food intake may be an important factor for patients to pursue. Our experience shows that bodily asymmetries are a major cause of the symptoms experienced by those branded into 'MS'. After seeing more than 200 patients presenting with 'MS' I am still looking for the first case of real 'MS'. All the patients we saw turned out to be victims of an asymmetry of their structure!
Patients who may suffer from symptoms such as described by the patients testimonial above must seek a TMJ and symmetry evaluation with the utmost urgency. Any delay makes the problem much worse and takes a lot longer to correct. Do not be mislead that you have some obscure auto-immune disease which, even the neurologists will admit, they know nothing about but are happy to prescribe you Steroids which will knock your hips out or drugs which will basically kill your immune system - an anathema in altruistic medical practice.
To find out how your TMJ dysfunction and other body asymmetries could be causing your 'MS' type symptoms please:
Monday, August 17. 2015
Multiple Sclerosis Increases the Risk of Venous Thromboembolism: A Nationwide Cohort Analysis.Chung WS, Lin CL, Tsai TC, Hsu WH, Kao CH.
Eur J Clin Invest. 2015. doi: 10.1111/eci.12502. [Epub ahead of print]
OBJECTIVES:The purpose of this study was to evaluate the effects of multiple sclerosis (MS) on the risk of venous thromboembolism (VTE) development.
METHODS:We identified patients diagnosed with MS in Taiwan between 1998 and 2010 by using the National Health Insurance Research Database and the Catastrophic Illness Patient Database (RCIPD). Each MS patient was frequency-matched to 4 controls according to age, sex, and the year of MS registration to the RCIPD. Patients with a history of VTE and incomplete information of age and sex were excluded. All patients were followed up from the index year until VTE diagnosis, loss to follow up, or the end of 2010. We calculated the hazard ratios (HRs) and 95% confidence intervals (CIs) of VTE in the MS and comparison cohorts by using Cox proportional hazards regression models.
RESULTS: We followed up 1238 MS patients and 4952 comparison patients for approximately 6437 and 27 595 person-years, respectively. After adjusting for age, sex, and comorbidities, the MS patients exhibited a 6.87-fold increased risk of VTE compared with the control patients. Women with MS were associated with an 11.1-fold increased risk of VTE development compared with the non-MS women (95% CI: 2.70-45.5). The MS patients aged < 50 years exhibited a 14.8-fold increased risk of developing VTE compared with age-matched patients in the comparison cohort (95% CI: 2.99-73.4). The risk of VTE development increased with the duration of hospitalization stay.
CONCLUSION: MS patients are associated with significantly greater risk of developing VTE compared with non-MS patients.
It may be a good idea to take a daily Aspirin.
Please check with your GP.
Sunday, June 28. 2015
New Research destroys the Auto-Immune Model of Multiple Sclerosis
Current MS treatment revolves around a false premise that immune cells should not be in the brain. Leading researchers from some leading universities have recently discovered that existing theories about the brain are simply not correct.
“Decades of medical theory which considered the brain as different from other organs of the body and without a lymphatic drainage system were, well...simply not correct.”
The Journal of Experimental Medicine said it best in their recent tweet:
The presence of a lymphatic vascular system:
Researchers at the University of Virginia School of Medicine have determined that the brain is directly connected to the immune system by vessels previously thought not to exist (published on Jun 23, 2015).
Study author Antoine Louveau, Ph.D., a postdoctoral fellow at the University Of Virginia School Of Medicine said:
“When we started our project, our question was if there are so many immune cells surrounding the brain, how do they traffic there? By addressing this question we found vessels that weren’t supposed to exist. They were very well hidden and we think that is why it took so long to discover them.” (Source)
Creating a myth:
These findings are of crucial importance to many who have been branded with 'Multiple Sclerosis'. The drug treatment of this illness is based on a FALSE premise that no immune cells should be in the brain and if they are there it is because of an autoimmune reaction which damages the myelin sheath thus preventing nerve conduction.
Let's learn the history:
The theory of 'immune privilege' was conceived to explain why foreign tissue grafts placed on brain tissue didn't cause an immediate immune reaction, as similar grafts did in other parts of the body, like the skin. It was believed that antigens in the brain were concealed from the immune system by the blood brain barrier. That's why it was assumed that when immune cells showed up in the brain--if they weren't there fighting an infection or as an inflammatory reaction after a stroke---there could only be one explanation--it was some sort of "auto-immune" and destructive inflammatory reaction.
Emaciating the immune system:
This speculation on 'immune privilege' has given birth to disastrous assumptions about the brain and has lead to the advent of immune system ablating drugs – in spite of widespread wisdom that maintaining a good immune system was of crucial importance in the care of any illness. Deaths due to the drugs have been scandalously often reported as deaths due to 'MS'.
Please note that 'the lesions' are actually watery masses with little evidence of demyelinating nerve tissue in most 'MS lesions'.
Standing up to real science:
The acceptance of EAE as a model for 'MS' is an error that has its basis on faith rather than science. The patients are charged up to $400,000 per annum for this faith based doctrine. The literature on immune-modifying therapy in 'MS' has been analysed and it is clear that none of these agents can qualify as a candidate therapy under scrutiny.
"Clinical trials of multiple sclerosis have been uniform in utilising invalidated outcome measures. This has occurred to a degree for which it is difficult to find parallels in medicine in general. We have recently evaluated the outcomes which have been used for evaluating past trials leading to drug approval and current trials. It is not a pretty sight.
A posting on another blog says:
"The 'MS' neurologists with "vested interest in the autoimmune hypothesis" were the very same ones who shut down CCSVI research before it could even begin, or be done correctly. They were the first to say that veins would have nothing to do with 'MS', that it was an autoimmune disease, that the brain's drainage system was unimportant. They created the narrative that those of us pleading for collaboration with Dr. Paolo Zamboni and the International Society of Neurovascular Disease (www.isnvd.org) were wackos, a fringe element, a Facebook/YouTube phenomena that would pass.
An impromptu poll conducted by Jenny on Facebook amongst 25 patients who had received CCSVI treatment revealed the following:
"These are the answers from 25 people who have been treated for CCSVI. I was the only one of 25 to have my dural sinuses checked. Most people were only investigated in the jugulars. About 20% gained complete symptom relief and about three quarters have sustained benefits. One lady was injured by her procedure, her right jugular vein ruptured because of over-ballooning and 25% of people got no benefit from angioplasty. I think there is still a lot to learn where CCSVI is concerned. There is no treatment consensus among treating doctors so the techniques and the areas investigated vary greatly as do the results."
A recent article concludes:
"By critical discourse analysis of the CCSVI discussion in a patient online forum, we reconstruct a lay discourse about the evidentiary value of knowledge. We detected evidence criteria in this lay discourse that are different from those in the expert discourse. But we should be cautious to interpret this dissociation as a sign of an intellectual incapability to understand scientific evidence or a naïve trust in experiential knowledge. Instead, it might be an indication of cognitive dissonance reduction to protect oneself against contradictory information."
The writing is on the wall, in medical journals, blogs and even twitter, says Joan Sapiro, who goes on to make a powerful argument to support her research:
"Some neurologists are saying there's no way the newly discovered lymphatic vessels and CCSVI are related. But they are wrong. Just as they have been wrong about the brain's "immune privilege" and the EAE mouse model of 'MS'".(Source)
The autoimmune model of 'MS' belongs to the garbage heap of history:
It is obvious that the cause of some patients lesions is a blocked or a compromised dural veinous drainage system. The autoimmune faith based and unscientific model of 'MS' has played out and now belongs to the garbage heap of history in spite of the daily publications of 'scientific studies' supporting this defunct hypothesis.
To further understand the success or failures of CCSVI, It is important to follow the course of the internal jugular veins which drain the dural sinuses of the brain.
1) The blockage of the dural sinuses appears to be a prominent factor in many patients symptoms. The cause often is the use of steroids which neurologists often pump in at the first sign or symptom of 'MS' such as optic neuritis. This is a know complication of heavy steroid use in such patients.
Further problems that patients suffer with which cannot be taken into consideration solely by a CCSVI hypothesis are:
If you wish to add some points or point out any mistakes please email me:
©2015 Dr. M. Amir. All rights reserved.
To find out how your TMJ dysfunction and other body asymmetries could be causing your 'MS' type symptoms please:
Friday, May 29. 2015
A patient recently wrote:
"One night while sleeping my teeth met together in a mildly clenching position I experienced tingling in my hands. This repeated a few times in the following days - when my teeth meet together during sleep or for the first time on waking up, I felt a mild tingling in the hands.
Over the next 24-48 hours after the disc reduces (with a click), the association between jaw movements and tingling reduces drastically.
These are some amazing observations by a patient. They are often considered to be a cardinal sign of 'MS'. Here is evidence that jaw dysfunction can produce these tingling sensations anywhere in the body. It is not a sign of 'MS' starting up.
To find out how your TMJ dysfunction and other body asymmetries could be causing your 'MS' type symptoms please:
Friday, May 15. 2015
I was diagnosed with Multiple Sclerosis in 1990 at the age of 21 although the first symptoms began when I was still in my late teens. I had started my own business when I was 19 designing and creating bridal gowns from my little shop in Watford. I had only been trading for eighteen months when I was faced with having to deal with being diagnosed with a chronic, progressive, incurable disease. I suppose I tried to ignore it in the early days and tried to pretend that it did not exist; I carried on with my dressmaking and busy social life.
Sunday, May 3. 2015
My wife has had PPMS for twenty two years. She has been told that there is no cure by the neurologists who are called the experts in MS. My wife has been completely paralysed to an extent that she cannot move her arms or legs at all. I have to turn her over a few times during the night to avoid bed sores.
Saturday, April 18. 2015
"Multiple sclerosis sufferers could be saved from blindness with new drug treatment" is today's headline news and an amazing claim in many newspapers.
"Epilepsy drug treats MS eye problems" says WebMD, one of the strongest online pill merchandisers.
"17th April 2015 -- "A drug designed to prevent epilepsy seizures may also help protect the eyesight of people with multiple sclerosis vision problems, according to new UK research".
In a small trial carried out by University College London, 86 people experiencing early symptoms of acute optic neuritis were given either the epilepsy drug phenytoin, or a placebo or dummy treatment for 3 months.
The aim was to see whether phenytoin could help to protect the light sensing retina nerve layer at the back of the eye.
The claim was "......These are promising results and if our findings are confirmed by larger studies, could lead to a new treatment that protects nerves from the damage caused in both optic neuritis and throughout the central nervous system in MS."
Here is how 'MS Research' jubilantly reports this 'amazing' discovery:
"The Phenytoin study also vindicates a large body of work from many laboratories studying sodium channel blockers as neuro-protective drugs in animal models of MS; ours included. In fact in our animal model Phenytoin was not the best drug, but we went with it as it is the only sodium channel blocker that can be loaded, i.e. you take a large first dose to get the drug levels therapeutic as soon as possible."
"We believe this good news for Relapsing/Remitting and Progressive MSers, as we are cracking that progressive nut. we have tested a hypothesis in animals and now we have done this in humans and it works! [HOORAY!]
.........It is incredibly rewarding when your ideas come to fruition and shows some value to humans and we are incredibly proud of the MD Team. TeamG and UCLP and this story has taken many years of hard work. [Really?]
..........Phenytoin is a generic [present retail cost $0.25 per tablet but the professor cannot let you get away with paying so little for a drug so he continues]...... and it will be difficult to develop but pharma have plenty of new molecules up their sleeve and could do an accelerated drug development process. Maybe this is why Biogen splashed out over $600 million to buy a sodium channel company. Maybe Novartis that makes Oxcarbazeppine have more compounds in their closet."[I can just hear the cash registers clunking - to hell with those branded into 'MS']
Let us see what Wikipedia says about some of the side effects of this 76 year old drug - Phenytoin (especially when loaded):
"At therapeutic doses, Phenytoin may produce nystagmus on lateral gaze." - This is a serious problem many MS sufferers already have and this drug could make it far worse.
"At toxic doses, patients can experience vertical nystagmus, double vision, slurred speech, cerebellar ataxia, and tremor." - All these are serious problems which MSers already suffer from and this drug will make these symptoms far worse.
"Phenytoin may accumulate in the cerebral cortex over long periods of time which can cause atrophy of the cerebellum. The degree of atrophy is related to the duration of Phenytoin treatment and is not related to dosage of the medication." - The cerebellar function is already seriously affected in MSers causing motor function loss and fine motor control loss. Brain atrophy is also an observation documented in many studies put out by the very same people promoting this dangerous drug. This drug will enhance these problems and put another nail in the coffin if this drug is continued for any length of time.
How the neurologists are so cock-a-hoop about its potential is quite beyond me.
It is more sand into unsuspecting patients eyes as happens daily with umpteenth articles and studies spewed out by the MS promoters.
"Optic neuritis is considered to be caused by the body's defence against infection, the immune system is thought to attack your body's own tissue" is the usual scam mantra.
This has never been proved and is pure speculation if not an outright concoction.
Optic neuritis usually gets better on its own. A large scale study, the Optic Neuritis Treatment Trial (ONTT), looked at the best way to treat optic neuritis in nearly 400 people. This trial found that regardless of whether treatment was given or not, over 90 percent of the people they followed for the study had an improvement in their sight within the first month from when vision loss began.
The study quoted above seriously questions this 'Phenytoin research'.
If in 90% of cases the patients recovered spontaneously within a month (this drug was actually tested over 3 months) what did this drug accomplish other than subject the patients to serious potential harm?
I ask the MS Promoters:
How can you implant an imposter drug into this possibly benign illness and then claim that the drug improved the symptoms when the patients actually got better spontaneously any way?
The drug causes havoc and actually makes the symptoms of the illness worse confirming the mantra that "MS is an incurable illness". Is this the grand secret of all DMT's? Make the benign illness worse and then claim 'MS' killed the patient!
Are these 'the scientific studies' that you so keep harking about?
Please click below to continue reading the rest of this article
Continue reading "Huge hoo-hah about epilepsy drug for Optic Neuritis - Success or outright deception? - You decide."
Thursday, April 16. 2015
Analysis of the MSers in the British Columbia MS study shows that treatment with interferon-beta did not prevent or delay the onset of SPMS.
Sunday, March 8. 2015
ARTEMIS - Anti-Retroviral Treatment for Epstein-Barr Virus in Multiple Sclerosis
This is the new name adopted for a study by the usual advocates of 'MS' as a mysterious and an incurable disease. This usually happens when there is perhaps a new drug in the offing. They are perhaps about to unleash an anti-viral drug.
On the viral front an analogy would perhaps help explain what may be in store for 'MS' patients.
It would be very lucrative to start selling an anti viral to MS patients so the advocates of 'MS' have added a new twist to justify their strategy:
Sunday, March 1. 2015
The "MS" storytellers have been pushing the point lately that dementia patients often develop "MS" symptoms or rather "Dementia precedes 'MS'". They have now gone one stage further and propose that "MS related dementia" should be called "MS-Associated Neurocognitive Disorder (MSAND)" .
Here is what the pharma teams have cleverly articulated through their mouthpiece:
Obviously when "MSAND" takes hold the anti immune drugs like the anti fungal Dimethyly Fumerate for the treatment of "MS", which presently sells for $55,000 per patient per year and is the biggest block buster drug and other useless, dangerous and sometimes lethal drugs, can be pushed onto unsuspecting and rebranded Dementia patients.
Wednesday, February 4. 2015
A man who has been unable to walk since contracting Polio as a young child is able to walk naturally again after becoming the first person to be fitted with a lower limb bionic exoskeleton.
This is a phenomenal development.
Sunday, January 25. 2015
Portable Neuromodulation Device May Improve Walking in MS Patients
A recent study suggests that MS patients can improve walking performance using a device called the Portable Neuromodulation Stimulator. By stimulating the tongue, researchers believe they can facilitate neuroplasticity in the motor nuclei of the cerebellum. In spite of the skepticism of many this makes a whole lot of sense to me and it should be given every opportunity to see if it assists patients with any kind of walking disability.
In spite of the skepticism of many this makes a whole lot of sense to me and it should be given every opportunity to see if it assists patients with any kind of walking disability.
(Page 1 of 2, totaling 28 entries) » next page
Sun, 25.01.2015 14:31
This does sound very credible to me, lets hope we get the o pportunity to try it for ourse lves. There is another v [...]Comments ()
Jen about The Persecution of Heretics
Tue, 06.01.2015 22:46
David Healy summarises the cor ruption we are up against in m edical care. "Most Western countries have signed up [...]Comments ()
Fri, 24.10.2014 15:34
*Big pharma has an interest in rich people being sick Wha t profit is there in a healthy population? If everyone [...]Comments ()
Jen about The great flu vaccination scam
Wed, 22.10.2014 13:32
Modern medicine is truly broke n. Today I read this article, GPs to be paid £55 for each de mentia diagnosis. The re [...]Comments ()
Wed, 17.09.2014 16:16
Another example is Lemtrada (f ormerly known as alemtuzumab o r Campath 1-H). This was forme rly licensed as a drug t [...]Comments ()
Doctor M. Amir about "Prescribing MS drugs is like shooting arrows into a dense fog"
Wed, 17.09.2014 15:58
An example is Dimethyl Fumerat e an antifungal in condemned Chinese sofas voted as the mos t allergenic molecule by [...]Comments ()
Wed, 17.09.2014 14:11
I was diagnosed with Multiple Sclerosis in 1990 at the age o f 21. My mobility had graduall y got worse over the yea [...]Comments ()
Doctor M. Amir about Cervical Spondylosis - Causes and treatment
Fri, 12.09.2014 17:03
Karen Thank you for an intere sting question. There is a gre at deal of confusion out there and I totally avoid rea [...]Comments ()
Fri, 12.09.2014 16:39
Hi Dr Amir, do you think that a Forward Head posture is caus ed by incorrect jaw position i n all cases? I assume th [...]Comments ()
Fri, 05.09.2014 15:48
The description of the disease seems to change according to the drug that’s being marketed . -Ray Peat, PhD Ther [...]Comments ()
Jen about Smouldering MS or TMJ dysfunction?
Mon, 21.07.2014 19:04
What a load of cobblers - what are the DMTs being pushed for ? Billions! http://www.gene ngnews.com/insight-and-i [...]Comments ()
Doctor M. Amir about No label more barbarous than 'Multiple Sclerosis'
Thu, 19.06.2014 21:45
"it does strengthen the sugges tion that PPMS, which is curre ntly considered untreatable, m ay respond to drugs that [...]Comments ()
Thu, 19.06.2014 12:59
And here the utter failure of the diagnostic 'evidence' to p rove the ludicrous 'sub-types ' of MS! PPMS vs. RRM [...]Comments ()
Doctor M. Amir about Treatment for Temporo Mandibular Joint Dysfunction
Wed, 18.06.2014 07:43
For those who do not know what the two procedues in jaw reha bilitation mean: Arthrocent esis: is the clinical pr [...]Comments ()
Tue, 17.06.2014 23:19
I saw this post on a TMJD page on Facebook and thought that I would share it here. Would y ou have any specific adv [...]Comments ()